Effect of recombinant human endostatin on microenvironment of human lung adenocarcinoma

Huang Gui,Chen Longbang

DOI: https://doi.org/10.3969/j.issn.1672-1535.2009.05.006

2009-01-01

Abstract:Purpose To study the effects of human recombinant human endostatin(rh-endostatin) on the microenvironment of human lung adenocarcinoma.Methods BALB/c nude mice were subcutaneously implanted with human adenocarcinoma cells and given rh-endostatin 5mg/kg s.c.daily for 14 days when tumor grew to about 100mm~3,with normal saline was administered as control.Seven days,14 days,and 21 days after the administration of rh-endostatin,the mice were sacrificed 30 minutes after intravenous injection of TRITC-Dextran(155kD) 50mg/kg.Tumor samples were excised for the examina- tion by fluorescence microscopy.The ratios of areas in the solid tumor where there was little TRITC - Dextran diffused were calculated.Results Fourteen days after administration of saline,the blood diffusion in the solid tumor was significantly lower than that on day 7 and day 21(10.01%±4.50%versus 1.49%±1.14%and 2.90%±2.02%).Rh-endostatin suppressed the blood diffusion at the tumor at the beginning of the treatment(day 7,the ratio of areas where there was little fluorescein distributed was 16.8%±4.02%).However,the blood diffusion increased by rh-endostatin 14 days after the treatment(P= 0.000) and there was no difference of blood diffusion between the two groups on day 21.Conclusion Rh-endostatin can transiently inhibit the blood diffusion in human adenocarcinoma.Furthermore,it can modulate the microenvironment by increasing the blood diffusion in a short period.